Transduction of ovarian cancer cells: a recombinant adeno-associated viral vector compared to an adenoviral vector

por Vermeij, J, Zeinoun, Z, Neyns, B, Teugels, E, Bourgain, C, De Grève, J
Publicado 2001

The Relationship between a New Biomarker of Vagal Neuroimmunomodulation and Survival in Two Fatal Cancers

por Gidron, Y., De Couck, M., Schallier, D., De Greve, J., Van Laethem, J. L., Maréchal, R.
Publicado 2018

Flemish breast cancer screening programme: 15 years of key performance indicators (2002–2016)

por Goossens, M., De Brabander, I., De Grève, J., Van Ongeval, C., Martens, P., Van Limbergen, E., Kellen, E.
Publicado 2019

Treatment algorithm in patients with ovarian cancer

por Vergote, I, Denys, H, De Greve, J, Gennigens, C, Van De Vijver, K, Kerger, J, Vuylsteke, P, Baurain, JF
Publicado 2020

An Observational Study of the First Experience with Bevacizumab for the Treatment of Patients with Recurrent High-Grade Glioma in Two Belgian University Hospitals

por Huylebrouck, M., Lv, S., Duerinck, J., Van Binst, A., Salmon, I., De Greve, J., De Witte, O., Luce, S., Michotte, A., D'Haens, J., Neyns, B.
Publicado 2012

PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment

por Thouvenin, J., Van Marcke, C., Decoster, L., Raicevic, G., Punie, K., Vandenbulcke, M., Salgado, R., Van Valckenborgh, E., Maes, B., Joris, S., Steichel, D. Vander, Vranken, K., Jacobs, S., Dedeurwaerdere, F., Martens, G., Devos, H., Duhoux, F.P., Rasschaert, M., Pauwels, P., Geboes, K., Collignon, J., Tejpar, S., Canon, J.-L., Peeters, M., Rutten, A., Van de Mooter, T., Vermeij, J., Schrijvers, D., Demey, W., Lybaert, W., Van Huysse, J., Mebis, J., Awada, A., Claes, K.B.M., Hebrant, A., Van der Meulen, J., Delafontaine, B., Bempt, I. Vanden, Maetens, J., de Hemptinne, M., Rottey, S., Aftimos, P., De Grève, J.
Publicado 2022